Domov › Lymfóm › North Carolina › Durham
Klinické štúdie Lymfóm v meste Durham, NC
17 štúdií pre Lymfóm hľadá účastníkov v zariadeniach v meste Durham a okolí (do cca 30 míľ). Otvorte štúdiu a zistite, kto sa môže zapojiť a ako kontaktovať tím.
Oficiálny text štúdie (anglicky)
Hľadáte účastníkov do štúdie? Zvýraznite ju na začiatku tejto stránky – $99 na 30 dní →
CD30 CAR for Relapsed/Refractory CD30+ T Cell Lymphoma
Prebieha náborFáza 2
- Lineberger Comprehensive Cancer Center at University of North Carolina, Chapel Hill · 10 míľ odtiaľ
A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)
Prebieha náborFáza 2
- Duke University, Durham
CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma
Prebieha náborFáza 1/2
- Duke University Medical Center, Durham
Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML
Prebieha náborFáza 1/2
- UNC School of Medicine, Division of Hematology, Chapel Hill · 10 míľ odtiaľ
DISCOVERY: Evaluating a Decision Support Tool for Adults Seen in Hematology/Oncology Clinics
Prebieha nábor
- Lineberger Comphrehensive Cancer Center at University of North Carolina, Chapel Hill · 10 míľ odtiaľ
Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
Prebieha náborFáza 1/2
- University of North Carolina at Chapel Hill/ University of North Carolina Medical Center, Chapel Hill · 10 míľ odtiaľ
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
Prebieha náborFáza 3
- Duke Cancer Institute, Durham
DALY II USA/ MB-CART2019.1 for DLBCL
Prebieha náborFáza 2
- Duke University Medical Center - Division of Hematologic Malignancies, Durham
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
Prebieha náborFáza 1
- Duke University Medical Center, Durham
Combating Cancer-Related Fatigue: A Personalized Supportive Care Program
Prebieha nábor
- North Carolina Basnight Cancer Hospital, Chapel Hill · 10 míľ odtiaľ
Registry of Older Patients With Cancer
Prebieha náborObservačná štúdia
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · 10 míľ odtiaľ
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
Prebieha náborFáza 1/2
- Duke University Medical Center, Duke Cancer Center, Durham
A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
Prebieha náborFáza 2
- University of North Carolina, Chapel Hill · 10 míľ odtiaľ
Symptom Management and Transitioning to Engagement With Post-treatment Care for Adolescent and Young Adult Cancer Survivors
Prebieha nábor
- Duke Cancer Institute, Durham
Study of Kappa Chimeric Antigen Receptor (CAR) T Lymphocytes Co-Expressing the Kappa and CD28 CARs for Relapsed/Refractory Kappa+ Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma.
Prebieha náborFáza 1
- Lineberger Comprehensive Cancer Center at University of North Carolina, Chapel Hill · 10 míľ odtiaľ
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
Prebieha náborObservačná štúdia
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · 10 míľ odtiaľ
A Randomized Phase II Study Of Bruton Tyrosine Kinase Inhibitor With Or Without Venetoclax In Veterans With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
Prebieha náborFáza 2
- Durham VA Medical Center, Durham, NC, Durham
Štúdie Lymfóm v iných mestách
- Houston, TX34 štúdií
- Boston, MA33 štúdií
- New York City, NY33 štúdií
- Washington, DC23 štúdií
- Baldwin Park, CA21 štúdií
- Chicago, IL20 štúdií
- St. Louis, MO15 štúdií
- Philadelphia, PA15 štúdií
- Cleveland, OH14 štúdií
- Edison, NJ12 štúdií
- Atlanta, GA12 štúdií
- Seattle, WA12 štúdií
Iné štúdie v Durham
- Rakovina prsníka63 štúdií
- Rakovina (všetky typy)58 štúdií
- Nemalobunkový karcinóm pľúc39 štúdií
- Mnohonásobný myelóm37 štúdií
- Metastatická rakovina33 štúdií
- Akútna myeloidná leukémia33 štúdií
- Rakovina pľúc32 štúdií
- Rakovina prostaty32 štúdií
- Kolorektálny karcinóm28 štúdií
- Chronická lymfocytová leukémia27 štúdií
- Rakovina vaječníkov27 štúdií
- Srdcové zlyhanie26 štúdií
Z ClinicalTrials.gov, dáta načítané 5. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.